share_log

哈药股份(600664.SH)发前三季业绩,净利润5.08亿元,同比增长74.97%

Harbin Pharmaceutical Group (600664.SH) released its performance for the first three quarters, with a net income of 0.508 billion yuan, a year-on-year increase of 74.97%.

Zhitong Finance ·  Oct 25, 2024 01:12

Harbin Pharmaceutical Group (600664.SH) released the Q1-Q3 report for 2024, achieving revenue...

According to the Zhitong Finance APP, Harbin Pharmaceutical Group (600664.SH) released the Q1-Q3 report for 2024. During the reporting period, the company achieved revenue of 12.256 billion yuan, a year-on-year growth of 6.63%; net income attributable to shareholders of the listed company was 0.508 billion yuan, a year-on-year growth of 74.97%; net income attributable to shareholders of the listed company after deducting non-recurring gains and losses was 0.47 billion yuan, a year-on-year growth of 91.39%; basic earnings per share were 0.20 yuan/share.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment